Clinical Effects of Soluble Dietary Fiber Supplementation
Study of Soluble Dietary Fiber on Colonic Transit Time and Clinical Symptoms in Adults With Slow-transit Constipation
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
The purpose of this study is to investigate the effect of pectin, a kind of soluble dietary fiber, on colonic transit time, clinical symptoms and the gut microbiota in adults with slow-transit constipation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started May 2009
Typical duration for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 17, 2014
CompletedFirst Posted
Study publicly available on registry
July 21, 2014
CompletedAugust 24, 2018
July 1, 2014
3.4 years
July 17, 2014
August 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
efficacy: intestinal transit time
colonic transit time
four weeks after inclusion
Secondary Outcomes (2)
efficacy: clinical symptoms
four weeks after inclusion
efficacy: gut microbiota
four weeks after inclusion
Study Arms (2)
soluble dietary fiber
EXPERIMENTALpectin, a kind of soluble dietary fiber
Placebo
NO INTERVENTIONPlacebo
Interventions
pectin (Andeli Ltd. Yantai, China), 24g/d for 4weeks
Eligibility Criteria
You may qualify if:
- All patients(age≧18y)
- Admitted for slow-transit constipation were considered eligible
You may not qualify if:
- Mental disorders
- Cancer
- Inflammatory bowel disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tao Gao, M.D.
Nanjing PLA General Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nanjing PLA General Hospital
Study Record Dates
First Submitted
July 17, 2014
First Posted
July 21, 2014
Study Start
May 1, 2009
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
August 24, 2018
Record last verified: 2014-07